Literature DB >> 35675303

Retraction: MicroRNA-153 Inhibits Osteosarcoma Cells Proliferation and Invasion by Targeting TGF-β2.

.   

Abstract

Entities:  

Year:  2022        PMID: 35675303      PMCID: PMC9176757          DOI: 10.1371/journal.pone.0269902

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.752


× No keyword cloud information.
Following the publication of this article [1], similarities were noted between this article and articles submitted by other research groups, including [2-10], of which one article [10] was previously retracted [11]. Similarities included the following figures which appear to partially overlap, despite being published in different articles and representing different conditions: Lanes 2–3 of the GAPDH panel in Fig 3D of [1], and lanes 1–2 of the GAPDH panel in Fig 4D of [6]. Although the corresponding author initially replied to acknowledge receipt of our message, PLOS ONE did not receive responses to the queries regarding these concerns by the end of the original deadline and extension. The unresolved concerns call into question the validity and provenance of the reported results and the adherence of this article to the PLOS Authorship policy. Therefore, the PLOS ONE Editors retract this article [1]. All authors did not comment on the retraction decision, did not respond directly or could not be reached.
  11 in total

1.  MicroRNA-561 inhibits gastric cancercell proliferation and invasion by downregulating c-Myc expression.

Authors:  Kun Qian; Binglang Mao; Wei Zhang; Huanwen Chen
Journal:  Am J Transl Res       Date:  2016-09-15       Impact factor: 4.060

2.  MicroRNA-575 targets BLID to promote growth and invasion of non-small cell lung cancer cells.

Authors:  Hongwei Wang; Chunhua Yan; Xiaodong Shi; Jiaolin Zheng; Lili Deng; Lei Yang; Fangfei Yu; Yuandi Yang; Yuxia Shao
Journal:  FEBS Lett       Date:  2015-02-26       Impact factor: 3.864

3.  MicroRNA-377 suppresses cell proliferation and invasion by inhibiting TIAM1 expression in hepatocellular carcinoma.

Authors:  Guolin Chen; Lu Lu; Chang Liu; Lei Shan; Di Yuan
Journal:  PLoS One       Date:  2015-03-04       Impact factor: 3.240

4.  Up-Regulation of MiR-300 Promotes Proliferation and Invasion of Osteosarcoma by Targeting BRD7.

Authors:  Zhen Xue; Jindong Zhao; Liyuan Niu; Gang An; Yashan Guo; Linying Ni
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

5.  MicroRNA-410 suppresses migration and invasion by targeting MDM2 in gastric cancer.

Authors:  Jianjun Shen; Weina Niu; Ming Zhou; Hongbo Zhang; Jun Ma; Ling Wang; Hongyan Zhang
Journal:  PLoS One       Date:  2014-08-19       Impact factor: 3.240

6.  MicroRNA-137 upregulation increases bladder cancer cell proliferation and invasion by targeting PAQR3.

Authors:  Youcheng Xiu; Zan Liu; Shunyao Xia; Chengjun Jin; Huaifu Yin; Weiming Zhao; Qiong Wu
Journal:  PLoS One       Date:  2014-10-16       Impact factor: 3.240

7.  MicroRNA-153 inhibits osteosarcoma cells proliferation and invasion by targeting TGF-β2.

Authors:  Guangfeng Niu; Bin Li; Li Sun; Chenggong An
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

8.  MicroRNA-33b suppresses migration and invasion by targeting c-Myc in osteosarcoma cells.

Authors:  Ning Xu; Zimu Li; Zhange Yu; Feng Yan; Yang Liu; Xiaofeng Lu; Weiliang Yang
Journal:  PLoS One       Date:  2014-12-29       Impact factor: 3.240

9.  MicroRNA-503 acts as a tumor suppressor in osteosarcoma by targeting L1CAM.

Authors:  Yang Chong; Jie Zhang; Xinzhen Guo; Guojun Li; Shiqian Zhang; Chao Li; Zhijian Jiao; Ming Shao
Journal:  PLoS One       Date:  2014-12-23       Impact factor: 3.240

10.  MicroRNA-217 regulates WASF3 expression and suppresses tumor growth and metastasis in osteosarcoma.

Authors:  Lei Shen; Peng Wang; Jili Yang; Xiaotao Li
Journal:  PLoS One       Date:  2014-10-07       Impact factor: 3.240

View more
  1 in total

1.  Retraction: MiR-144 Inhibits Uveal Melanoma Cell Proliferation and Invasion by Regulating c-Met Expression.

Authors: 
Journal:  PLoS One       Date:  2022-08-31       Impact factor: 3.752

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.